BioRestorative Therapies, Inc. - FORM 10-K - EX-23 - March 21, 2017

Attached files

file filename
EX-10.70 - BioRestorative Therapies, Inc.ex10-70.htm
EX-32 - BioRestorative Therapies, Inc.ex32.htm
EX-31.2 - BioRestorative Therapies, Inc.ex31-2.htm
EX-31.1 - BioRestorative Therapies, Inc.ex31-1.htm
EX-21 - BioRestorative Therapies, Inc.ex21.htm
EX-10.69 - BioRestorative Therapies, Inc.ex10-69.htm
EX-10.68 - BioRestorative Therapies, Inc.ex10-68.htm
EX-10.67 - BioRestorative Therapies, Inc.ex10-67.htm
EX-10.66 - BioRestorative Therapies, Inc.ex10-66.htm
EX-10.65 - BioRestorative Therapies, Inc.ex10-65.htm
EX-10.64 - BioRestorative Therapies, Inc.ex10-64.htm
EX-10.63 - BioRestorative Therapies, Inc.ex10-63.htm
EX-10.62 - BioRestorative Therapies, Inc.ex10-62.htm
EX-10.61 - BioRestorative Therapies, Inc.ex10-61.htm
EX-10.60 - BioRestorative Therapies, Inc.ex10-60.htm
EX-10.59 - BioRestorative Therapies, Inc.ex10-59.htm
EX-10.58 - BioRestorative Therapies, Inc.ex10-58.htm
EX-10.37 - BioRestorative Therapies, Inc.ex10-37.htm
EX-10.10 - BioRestorative Therapies, Inc.ex10-10.htm
EX-10.1 - BioRestorative Therapies, Inc.ex10-1.htm
10-K - BioRestorative Therapies, Inc.form10-k.htm

 

Exhibit 23

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the incorporation by reference in the Registration Statements of BioRestorative Therapies, Inc. (the “Company”) on Form S-8 (File Nos. 333-196299, 333-203310, 333-210555 and 333-214621) of our report dated March 21, 2017, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of BioRestorative Therapies, Inc. as of December 31, 2016 and 2015 and for the years then ended, which report is included in this Annual Report on Form 10-K of BioRestorative Therapies, Inc. for the year ended December 31, 2016.

 

/s/ Marcum llp  
Marcum llp  
New York, NY  
March 21, 2017  

 

  
  

BioRestorative Therapies, Inc. Reports